Servatus Biopharmaceuticals Joins Microbiome Therapeutics Innovation Group
WASHINGTON, March 29, 2021 /PRNewswire/ — The Microbiome Therapeutics Innovation Group (MTIG) announced today the addition of Australian Biotech company Servatus Biopharmaceuticals Ltd to its coalition of companies leading the research and development of FDA-approved microbiome…
Comments Off on Servatus Biopharmaceuticals Joins Microbiome Therapeutics Innovation Group